Clinical Research Consulting
The decisions made before and during a clinical programme can shape its timelines, evidence and long-term value. Our consultants help you examine those decisions from scientific, clinical, regulatory and operational perspectives.
We work alongside your team to define development pathways, assess risks and translate complex questions into practical next steps. Support can begin with a specific challenge or extend across your programme, with senior specialists remaining close as the evidence evolves.
Full-service CRO
Clinical trials depend on many connected activities, but sponsors should not have to manage disconnected providers. As a pan-European full-service CRO, Clarenta brings clinical operations, project management, regulatory affairs, medical oversight, data management, biostatistics, pharmacovigilance and other essential disciplines into one accountable delivery model.
Our teams connect planning with execution, maintain clear visibility across the study and address emerging risks before they become larger problems. You remain informed about what is happening, why it matters and what comes next.
Phase I Unit
Early clinical studies require controlled execution, intensive procedures and timely access to reliable data. Clarenta’s Phase I Unit in Sofia supports studies in healthy volunteers and patients, with experienced clinical teams, an on-site pharmacy and a clinical laboratory supporting participant monitoring.
Because the unit is connected to our wider early development expertise, clinical conduct, sample pathways, data review and programme decisions remain aligned. Sponsors gain a clear operational view from study preparation and first dosing through close-out and the decisions that follow.
Experience grounded in clinical delivery
Across 29 years and more than 950 clinical trials, Clarenta has supported programmes across therapeutic areas, development phases and European markets. This experience helps our teams recognise where complexity is likely to emerge and bring the right questions forward earlier.
Our scale allows us to provide multidisciplinary capabilities across Europe while keeping senior expertise accessible and your programme visible. You gain a partner invested in both the immediate study and the decisions it needs to support.